NCT00691145View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Dermatitis, Atopic
Interventions
DRUG

tacrolimus ointment

transdermal

Trial Locations (26)

10126

Torino

16132

Genova

20100

Milan

24100

Bergamo

27100

Pavia

28100

Novara

30122

Venezia

34149

Trieste

39100

Bolzano

39102

Merano

42100

Reggio Emilia

43100

Parma

46100

Mantova

53100

Siena

60020

Ancona

70124

Bari

71013

S. Giovanni Rotondo

80100

Napoli

82100

Benevento

84091

Battipaglia

95124

Catania

98100

Messina

06100

Perugia

00133

Roma

00141

Roma

07100

Sassari

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY